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Key Points:  
• Depletion of Hoxa genes reduces the engraftment potential of adult HSCs 
• Ectopic overexpression of Hoxa9 partially restores Hoxa-/- HSC activity 
  
ABSTRACT 
 
Determination of defined roles for endogenous homeobox (Hox) genes in adult 
hematopoietic stem and progenitor cell (HSPC) activity has been hampered by a 
combination of embryonic defects and functional redundancy. Here we show that 
conditional homozygous deletion of the Hoxa cluster (Hoxa-/-) results in marked 
reduction of adult HSPC activity, both in vitro and in vivo. Specifically, Hoxa-/- HSPCs 
proliferate much less than wild type cells in vitro and they are also much less 
competitive in vivo. Notably loss of Hoxa genes had little impact on HSPC differentiation. 
Comparative RNA sequencing analyses of Hoxa-/- and wild type HSCs (CD150+/CD48-
/Lineage-/c-kit+/Sca-1+ (LKS)) identified a large number of differentially expressed genes 
(P<0.004), three of which (Nr4a3, Col1a1 and Hnf4a) showed >10-fold reduced levels. 
Engineered overexpression of Hoxa9 in Hoxa-/- HSCs resulted in partial phenotypic 
rescue in vivo with associated recovery in expression of a large proportion of 
deregulated genes. Together, these results provide definitive evidence linking Hoxa 
gene expression to proliferation of adult HSPCs.    
  
INTRODUCTION 
Specific developmental phenotypes are associated with loss of individual Hoxa 
cluster genes in the mouse 1-4. Interestingly, most of these Hoxa genes are expressed in 
hematopoietic cells, with the highest levels in primitive hematopoietic stem and progenitor 
cells (HSPC) and much lower levels in mature cells 5-8. 
 Evaluation of individual Hoxa gene mutant mice has provided only limited insight 
into their role in adult hematopoiesis, indicative of a level of functional redundancy of 
“cluster genes” in this tissue 1,9,10. The Hoxa9 homozygous null mice display the most overt 
hematopoietic phenotype characterized by mild leucopenia resulting from bone marrow 
(BM) hypocellularity, particularly of myeloid and B cells. This phenotype is associated with 
impairment in activity, not the number, of the long-term (LT) HSCs 11. 
Further supporting the importance of Hoxa genes in hematopoiesis, we previously 
showed that heterozygous Hoxa cluster (Hoxa+/-) adult LT-HSCs are less competitive than 
wild-type cells in transplantation assays 5. Moreover Di Poi et al. previously reported that 
recipients of fetal liver-derived LT-HSCs in which Hoxa gene expression is reduced to 20% 
(called HoxAc/- cells 12) have impaired ability to repopulate adult mice particularly in the 
output of early erythrocytes. This phenotype was much less obvious in HoxAc/- newborn 
mice possibly indicating that Hoxa cluster genes are more important in activity of adult 
versus fetal HSPCs.  
To address this point, we now assess the impact of the complete ablation of Hoxa 
cluster genes in adult HSPCs and explore the consequence of this deletion on the 
transcriptome using RNA sequencing (RNASeq). Results definitively establish an essential 
function for Hoxa genes in proliferation, but not differentiation, of adult HSPCs.  
  
METHODS  
Mice and Hoxa gene deletion 
To delete the Hoxa locus Hoxaflox/flox(f/f)/MxCre mice13 and MxCre controls received 7 
injections of 10 µg pIpC (GE healthcare life sciences, Baie-d'Urfé, QC, Canada) per 
gram body weight for a maximum of 250 µg per mice intraperitoneally every 2 days.  
Hoxa cluster deletion was confirmed by PCR.  
 
Infection of primary BM cells 
Lineage (LIN)- BM cells were purified from Hoxa-/- and control mice 4 weeks post pIpC, 
and transfected with MSCV-pgkGFP or MSCV-HOXA9-pgkGFP retroviral supernatants 
by spinoculation (2250 rpm) for 90 minutes.  After 48 hours 0.25 x 106 sorted GFP+ were 
intravenously injected without helper cells, in irradiated (8 Gy) adult B6SJL congenic 
recipient mice. 
 
RNA isolation and RNA-Seq library preparation 
Total RNA was extracted from 60,000-100,000 Hoxa-/- and control LT-HSC 
(CD150+/CD48-/LKS) and used to generate transcriptome libraries. Paired end (2 x 100 
bp) sequencing was performed using an Illumina HiSeq2000 (Illumina, San Diego, CA, 
US). RNASeq data were analysed with CuffDiff or the DeSeq R package 14. 
 
RESULTS AND DISCUSSION 
 MxCre-induced conditional deletion of Hoxa genes in adult HSPCs resulted in 
significant reduction of white blood cells, red blood cells and platelets in the peripheral 
blood and moderate reductions in cellularity in all hematopoietic organs, primarily due to 
a severe decrease in B cells (Figure S1A-D). Flow cytometry and clonogenic assays 
also demonstrated reduced HSPCs (Figure 1A, S1E-G and confirmation of deletion in 
1D), consistent with observations made in FL-derived HoxAc/- HSCs 12.  However unlike 
the fetal derived equivalents, adult Hoxa-/- HSCs (CD150+/CD48-/LKS) demonstrated 
reduced proliferation potential in vitro (Figure S1H), but were more in cycle in vivo 
(Figure S2B, C). In accordance with the in vitro results, Hoxa-/- BM cells demonstrated 
reduced ability in reconstituting irradiated congenic hosts compared to wild type controls 
(Figure 1B and S1I-J) that is partly due to an increase in apoptosis (Figure S2D, E), but 
not due to homing defects or non-Hoxa-deleted escapees (Figure S2F-H). Repopulation 
ability of Hoxa-/- cells was completely absent in secondary recipients, in contrast to 
control cells, suggesting an exhaustion of the HSC pool (Figure S1K). In this in vivo 
model B cells were also underrepresented, while Hoxa-/- cells reconstituted most other 
cell lineages proportionally (Figure 1C and S1L). These data confirm our earlier 
observation that adult HSC-derived B cells have an increased sensitivity for Hoxa gene 
levels 5, compared to fetal HSC-derived B cells 12. 
  
Comparative RNASeq transcriptome data from Hoxa-/- and control HSCs 
identified 881 significantly differentially expressed genes, the vast majority of which 
(614) were downregulated (supplementary Table S1). Functional annotation clustering 
using Gene Ontology terms revealed that differentially expressed genes were 
associated with cell proliferation and differentiation, cell activation, signalling, regulation 
of gene expression, hematopoiesis, migration and apoptosis (Table S2). Moreover, 
differentially expressed genes were associated with several pathways according to the 
Kyoto Encyclopedia of Genes and Genomes (KEGG), which included hematopoietic cell 
lineage and cancer pathways, supporting a known role for Hoxa genes in hematopoiesis 
and leukemia (Table S3).  
Only 13 genes expressed at Reads Per Kilobase of transcript per Million mapped reads 
(RPKM) values >1 showed greater than 10-fold differential expression between the 2 
conditions (Figure 1E, Table S1). Genes downregulated in Hoxa-/- cells were mostly from 
the Hoxa cluster (Figure 1E and F), but also included Nr4a3, Col1a1 and Hnf4a.  Nr4a3, 
also known as Nor-1, codes for an orphan nuclear receptor transcription factor highly 
homologous to Nr4a1 (Nur77) and Nr4a2 (Nurr1). Co-deficiency of Nor-1 and Nur77 is 
associated with an aggressive AML 15, while individual mutants have only weak 
phenotypes both related to proliferation and apoptosis 16,17. The latter phenotype 
corresponds with those for the Hoxa-/-, indicating that Nr4a3 may have contributed to the 
Hoxa-/- phenotype. Two genes, Hoxb8 and Mir196a-1, were significantly upregulated 
(>10-fold) in Hoxa-/- HSCs (Figure 1E and G), possibly pointing to cross-regulation 
between Hoxa and Hoxb cluster genes and their inter-cluster-located Mir’s 18,19. 
We next investigated if overexpression of a single Hox gene, Hoxa9, could at 
least in part, rescue the HSPC phenotype found in recipients of Hoxa-/- cells. Hoxa-/- 
HSPCs were transduced with Hoxa9 or control GFP virus and transplanted into 
congenic animals. With the exception of the B cell lineage, we found that Hoxa9 
overexpression indeed restored HSPC engraftment to levels found with control wild type 
cells (Figure 2A-D). However and in line with our previous observations 5, B cell 
numbers remained persistently lower in these mice (Figure 2C).  Most importantly, 
overexpression of Hoxa9 provided a recovery at the molecular level of over 70% (14 of 
19) deregulated genes found in Hoxa-/- mutant (Figure 2E).   
Together the data identifies a critical role for Hoxa cluster genes in adult HSPC 
function, and identifies a Hoxa gene-dependent gene signature that underlies this 
function.   
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LEGENDS TO THE FIGURES 
Figure 1. Deletion of Hoxa cluster genes in adult mice and transcriptome analysis 
of Hoxa-/- HSCs. 
(A) Bar graphs depicting absolute numbers of CD150+/CD48-/CD244-/LKS HSCs (n=4) 
and CD150+/CD48-/CD244+/LKS MPPs in BM of Hoxa-/- and control mice. BM cells 
isolated from femur and tibia 4 weeks after pIpC injection. (B) Engraftment of Hoxa-/- 
(n=14) and control (n=15) cells in the PB, BM, spleen and thymus of recipient mice at 
~24 weeks after transplantation. Each dot represents a CD45.1 recipient mouse 
transplanted with 106 congenic CD45.2 BM cells. (C) Proportions of B (B220+), myeloid 
(Mac1+), T (CD3+) and erythroid (Ter119+) cells in PB of reconstituted mice shown in (B). 
(D) PCR analysis showing the deletion of the Hoxa cluster in purified LKS cells at 4 
weeks following the last pIpC injection (n=5). (E) Scatterplot showing transcriptome 
analysis of genes that were up- (above axis) or down-regulated (below axis) in Hoxa-/- 
versus wild type control CD150+/CD48-/LKS cells sorted 1 month after the last pIpC 
injection. Values are expressed as average (log10((average RPKM)*1000+1)). Cut off 
limit for showing gene identify was set at 3, approximately representing a RPKM value of 
0.1. Highlighted genes show 10-fold differences between the 2 groups. (F-G) 
Comparative expression of Hoxa (F) and Hoxb (G) genes in pairs of Hoxa-/- and control 
HSC samples (n=3). *P<0.05, **P<0.01, ***P<0.001, N.S., non-significant; MPP, multi-
potent progenitors; HSC, hematopoietic stem cells; BM, Bone marrow; PB, peripheral 
blood. 
 
Figure 2. Rescue of Hoxa-/- HSC engraftment by overexpression of Hoxa9. 
(A) Average kinetics of engraftment in mice receiving 0.2 x 106 of either control Hoxa+/+ 
+ GFP (n=13), Hoxa-/- + GFP (n=5) and Hoxa-/- + Hoxa9-GFP (n=6) BM cells. 
Percentage of donor cells are measured by flow cytometry for GFP+ in the PB at 
indicated times. (B) Long-term engraftment of HSCs with indicated genotype in 
individual mice 16 weeks post-transplantation. (C) Percentage of Hoxa+/+ + GFP and 
Hoxa-/- + Hoxa9 derived B cells (B220+), T cells (CD3+), myeloid cells (Mac1+) and 
erythroid cells (Ter119+) in the PB of individual mice 16 weeks post-transplantation. (D) 
Bar graphs depicting percentage of Hoxa+/+ + GFP and Hoxa-/- + Hoxa9 CD150+/CD48-
/LKS HSCs (n=3) and MPPs (n=3) in GFP+ cell population. (E) Gene expression 
analysis in RNAseq HSC and Lin- cells overexpressing Hoxa9. ¤ indicates quantity not 
sufficient defined as corrected CT value >36. *P<0.05, **P<0.01, ***P<0.001, N.S., non-
significant; MPP, multi-potent progenitors; HSC, hematopoietic stem cells; BM, Bone 
marrow; PB, peripheral blood; CT, cycle time. 
 


